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ORIGINAL RESEARCH • CARDIAC IMAGING
P
atients with left-sided heart disease commonly develop 
pulmonary hypertension (PH) (1), initially resulting 
from passive backward transmission of high left ventricular 
illing pressures through the pulmonary circulation. Some 
patients with postcapillary disease may subsequently de-
velop a degree of precapillary vascular remodeling due to 
prolonged elevation of pulmonary arterial pressure (2–9). 
Previously, the diference between mean pulmonary arte-
rial pressure (mPAP) and pulmonary arterial wedge pres-
sure (PAWP), termed the transpulmonary gradient (TPG), 
was used to identify patients with PH out of proportion to 
left-sided heart disease. Subsequently, a study by Gerges 
et al (2) identiied the diastolic pulmonary pressure gradi-
ent (DPG), which was calculated by subtracting mean 
PAWP from diastolic pulmonary artery pressure, as a su-
perior prognostic parameter in patients with postcapil-
lary disease. he Fifth World Symposium on Pulmonary 
Hypertension introduced the classiication of combined 
pre- and postcapillary PH (Cpc-PH), deined as an mPAP 
level of at least 25 mmHg, a PAWP level greater than 15 
mmHg, with either a DPG of 7 mmHg or more or pul-
monary vascular resistance (PVR) greater than 3 WU (10). 
Patients with Cpc-PH are at greater risk for deterioration 
than are those with isolated postcapillary PH (Ipc-PH) but 
may beneit from PAH-speciic therapy, especially in the 
context of randomized controlled trials (9,11,12) (https://
ClinicalTrials.gov identiier, NCT02070991).
Previous noninvasive MRI techniques were used to 
measure left atrial volume index (13), echocardiographic 
parameters (14), or a combination of clinical, electrocar-
diographic, and echocardiographic features (6) and can be 
used to distinguish between pre- and postcapillary disease. 
However, there is currently no noninvasive method to 
identify patients likely to have Cpc-PH.
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Purpose: To assess interventricular septal (IVS) angle in the identiication of combined pre- and postcapillary pulmonary hyperten-
sion (Cpc-PH) in patients with pulmonary hypertension (PH) due to left-sided heart disease.
Materials and Methods: In this retrospective study, consecutive, incident patients suspected of having PH underwent same-day right-
sided heart catheterization (RHC) and MRI at a PH referral center between April 2012 and April 2017. he diagnostic accuracy of 
the IVS angle to identify Cpc-PH in patients with pulmonary arterial wedge pressure (PAWP) greater than 15 mmHg was assessed 
by using receiver operator characteristic curves, sensitivity, speciicity, and negative and positive predictive values. IVS angle also was 
assessed as a predictor of all-cause mortality by using Cox uni- and multivariable proportional hazards regression.
Results: A total of 708 patients underwent same-day MRI and RHC, and 171 patients had PAWP greater than 15 mmHg. Mean 
age was 70 years (range, 21–90 years) (women: mean age, 69 years; range, 21–88 years) (men: mean age, 71 years; range, 43–90 
years). Systolic IVS angle correlated with diastolic pulmonary gradient (DPG) (r = 0.739, P , .001). Receiver operating charac-
teristic curve analysis showed septal angle enabled identiication of Cpc-PH (DPG  7), with an area under the receiver operating 
characteristic curve of 0.911 (P , .001). A 160° threshold, derived from the irst half of patients with raised PAWP, enabled iden-
tiication of a DPG of at least 7 mmHg with 67% sensitivity and 93% speciicity (P , .001) in the second cohort of patients with 
raised PAWP. IVS angle was predictive of all-cause mortality (standardized univariable hazard ratio, 1.615; P , .01).
Conclusion: he systolic interventricular septal angle is elevated in patients with combined pre- and postcapillary pulmonary hyper-
tension and enables one to predict those patients who have PH due to left-sided heart disease who have an increased risk of death.
Published under a CC BY 4.0 license.
Online supplemental material is available for this article.
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Abbreviations
CI = conidence interval, Cpc-PH = combined pre- and postcapillary 
pulmonary hypertension, DPG = diastolic pulmonary gradient, Ipc-PH = 
isolated postcapillary pulmonary hypertension, IVS = interventricular 
septum, mPAP = mean pulmonary arterial pressure, PAWP = pulmo-
nary arterial wedge pressure, PH = pulmonary hypertension, PVR = 
pulmonary vascular resistance, RHC = right-sided heart catherization
Summary
he systolic interventricular septal angle measured at MRI is elevated in 
patients with combined pre- and postcapillary pulmonary hypertension 
in patients with left-sided heart disease; the interventricular septal angle 
enables one to predict which patients are at risk for a poor outcome.
Implications for Patient Care
 n Patients with combined pre- and postcapillary pulmonary  
hypertension are at risk for a poor outcome and may beneit  
from targeted pulmonary vascular therapy.
 n he interventricular septal angle measured with MRI is elevated  
in patients with combined pre- and postcapillary pulmonary  
hypertension.
 n he interventricular septal angle measured with MRI enabled  
prediction of patients who have an increased risk of death.
he aim of our study was to assess interventricular septal 
angle in the identiication of Cpc-PH in patients with PH owing 
to left-sided heart disease.
We hypothesized that structural and functional imaging of 
the heart using cardiac MRI, speciically the interventricular sep-
tal angle, could enable diferentiation of Cpc-PH from Ipc-PH.
Materials and Methods
Ethical approval was granted by the local ethics committee, 
and institutional review board approval was attained for our 
retrospective study. Written informed consent was waived (ref 
c06/Q2308/8).
Consecutive incident patients suspected of having PH who 
underwent cardiopulmonary MRI at a PH referral center (15) 
from April 2012 to April 2017 were identiied. All incident cases 
with MRI and right-sided heart catherization (RHC) on the 
same day were included. Our main study population comprised 
patients with left-sided heart disease diagnosed at RHC 
(PAWP . 15 mmHg). hese patients were split into a deriva-
tion and validation cohort by date of imaging (October 1, 2016). 
he remaining incident patients with a normal PAWP were used 
as a comparison group to assess the underlying mechanism.
Image Acquisition and Analysis
All patients underwent cardiac 1.5-T MRI at the PH refer-
ral center as part of the routine clinical pathway. Short-axis 
steady state free-procession images were acquired with stan-
dard protocols, as previously described (16) and available in 
Appendix E1 (online). MR images were analyzed by a radiog-
rapher with 9 years of cardiac MRI experience (D.C.) on a GE 
Advantage Workstation 4.4 using GE Advantage Workstation 
ReportCard software (GE Healthcare, Milwaukee, Wis), with 
the observer blinded to all clinical information and results of 
other investigations. he interventricular septum (IVS) an-
gle was measured as the angle formed between the insertion 
points of the ventricles to the midpoint of the septum, mea-
sured at end-systole (17–19). Figure 1 shows the IVS angle in 
one patient with high DPG and another with normal DPG. 
he standard cardiac contours and metrics were measured 
and calculated (16,20), as previously published. A description 
of these is available in Appendix E1 (online). hese standard 
cardiac MRI metrics have previously been shown to have ex-
cellent interobserver reproducibility (21).
RHC Procedure
RHC was performed at the PH referral center by using a 
balloon-tipped 7.5-French thermodilution catheter (Becton-
Dickinson, Franklin Lakes, NJ) introduced via a Swann-Ganz 
catheter, usually via the internal jugular vein. Left-sided heart 
disease was deined as PAWP greater than 15 mmHg (10). 
DPG was calculated as diastolic pulmonary arterial pressure 
minus PAWP (4), with a DPG of 7 mmHg or higher con-
sidered diagnostic for combined pre- and postcapillary PH 
(10,22). Cardiac output was measured with thermodilution. 
PVR was deined as the diference of mPAP minus PAWP, 
which was then divided by cardiac output. Further analysis was 
performed by using PVR, with a threshold of greater than 3 
Woods units (240 dyne·sec) to assess the IVS angle as a marker 
for Cpc-PH using both potential methods.
Statistical Analysis
To test the accuracy of cardiac MRI parameters in the assess-
ment of DPG, initial analysis was performed in all patients 
with PAWP greater than 15 mmHg. he Pearson correlation 
coeicient was calculated between each variable and DPG, 
transpulmonary gradient, and PVR. Scatterplots of each met-
ric were interrogated to ensure linearity. To identify a suitable 
diagnostic threshold, the receiver operating characteristic curve 
was analyzed in the irst half, and the Youden index was used to 
select a suitable threshold. In the second half of the patient co-
hort, the 2 3 2 contingency table and the x2 test were used to 
determine sensitivity, speciicity, and positive and negative pre-
dictive values for the threshold derived in the training cohort.
To assess the hemodynamic basis of the IVS angle as a marker 
of DPG, the Pearson correlation coeicient of septal angle and 
DPG with mean systolic and diastolic pulmonary arterial–to-
systemic pressure ratios were analyzed. In the full cohort of cases, 
the IVS angle in each group of patients with PH (by cause [10]) 
was compared by using analysis of variance. he correlation coef-
icient between the septal angle against the DPG and the mean 
pulmonary arterial pressure was calculated for each group.
To assess the underlying mechanism for the IVS angle as a 
marker of the DPG, linear regression analysis of signiicant can-
didate MRI correlates was assessed. For linear regression analysis, 
the z score from the population with raised PAWP was calculated 
as follows: xz NT
 , where µ is the mean and s is the standard 
deviation, to enable comparison of the independent associations 
of MRI metrics with DPG. DPG was considered the dependent 
variable and any MRI metric with a signiicant correlation with 
DPG was considered a predictor.
Analysis of outcome was performed in the patients with 
increased PAWP. Our study period stretched from MRI to 
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Figure 1: Representative images in a patient with a negative diastolic pulmonary pressure 
gradient and a normal septal angle (left) and a patient with an elevated diastolic pulmonary 
gradient (DPG) and a high septal angle (right).
Figure 2: Flowchart shows patient inclusion criteria. PAWP 
= pulmonary artery wedge pressure, PH = pulmonary hyperten-
sion, RHC = right-sided heart catheterization.
census (June 16, 2017) or all-cause mortality. Survival analysis 
was performed by using Cox proportional hazards regression 
analysis and the log-rank test at Kaplan-Meier curve analysis. 
For Cox regression, metrics were standardized with the z score. 
Kaplan-Meier plots were constructed by 
using recognized thresholds, when avail-
able. For IVS angle, the threshold from 
the Youden index in the irst cohort 
of patients (160°) was used. Receiver 
operating characteristic curve analysis 
was used to predict death at 2 years from 
study enrollment, as this time point had 
a balance of patients who reached census 
(n = 122) and who died (n = 36). Survival 
analysis of six variables was performed; 
the Bonferroni correction was used, and P 
, .008 indicated a signiicant diference.
Reproducibility was assessed in 20 
patients by a general radiologist (C.S.J.) 
with an interest in thoracic imaging and 6 
years of experience, as per the standard re-
producibility method, which is outlined 
in Appendix E1 (online).
Statistical analysis was performed by 
using SPSS, version 22 (IBM, Chicago, 
Ill) and GraphPad Prism 7 (GraphPad 
Software, San Diego, Calif ). P ,.05 in-
dicated a signiicant diference, and data 
are presented as mean 6 standard devia-
tion, unless otherwise stated.
Results
In our study, 2643 patients underwent cardiopulmonary MRI. 
A total of 1315 patients underwent initial diagnostic imaging: 
of these, 758 underwent MRI and RHC on the same day. In 
50 patients, PAWP was not recorded. A total of 171 patients 
had PAWP greater than 15. Figure 2 shows the algorithm for 
patient selection.
Identification of High Diastolic Pulmonary Gradient
Mean age of patients was 70 years (range, 21–90 years), and 
61% were women (mean age, 69 years; age range, 21–88 
years) (men: mean age, 71 years; age range, 43–90 years). 
Fifty-six (33%) patients had a DPG of 7 mmHg or higher, 57 
(33%) had a DPG of 0–6.9 mmHg, and 58 (34%) had a nega-
tive DPG. Table 1 presents the demographic and RHC data. 
Five patients did not have PH (all had DPG , 7 mmHg). A 
total of 103 patients had PH due to left-sided heart disease 
alone, 32 had combined pre- and postcapillary PH, 17 had 
coexistent lung disease, and 19 had coexistent chronic throm-
boembolic disease, as deined in the multidisciplinary team 
meeting. Left-sided heart disease was due to left ventricular 
diastolic dysfunction in 149 cases, left ventricular systolic dys-
function in nine, and valve disease in 13 (mitral regurgitation, 
n = 5; aortic stenosis, n = 5; aortic regurgitation, n = 1; mixed 
mitral and aortic disease, n = 1; unknown, n = 1). A total of 
127 patients did not undergo vasodilator therapy, 31 received 
sildenail alone, and 13 underwent dual therapy (sildenail 
with macitentan, n = 8; bosentan, n = 4; ambrisentan, n = 
1). In the Cpc-PH group, 13 patients had coexistent chronic 
thromboembolic PH, and nine had coexistent lung disease. 
Combined Pre- and Postcapillary Pulmonary Hypertension
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Of these patients, 25 did not undergo vasodilator therapy, 
19 received sildenail alone, and 12 underwent dual therapy 
(sildenail with macitentan, n = 8; bosentan, n = 4).
Systolic IVS angle correlated with DPG (r = 0.739, P , .001) 
and PVR (r = 0.626, P , .001). Figure 3 presents scatterplots 
of IVS angle against DPG and PVR. he correlation of IVS an-
gle with DPG was greater in the group with elevated DPG (R 
Table 1: Baseline Patient Demographics, Hemodynamics, and Cardiac MRI Metrics in Patients with Pulmonary Arterial 
Wedge Pressure Greater than 15 mmHg, Split by the Diastolic Pulmonary Gradient
Characteristic All (n = 171) DPG , 0 (n = 58) DPG 0–6.9 (n = 57) DPG  7 (n = 56) P Value
Age (y) 70 6 10 70 6 10 71 6 10 69 6 11 .638
Sex (female/male) 105/66 (61/39) 38/20 (66/64) 34/23 (60/40) 33/23 (59/41) .727
WHO functional class (I, II, III, IV) 0, 18, 143, 9 
(0, 11, 84, 5)
0, 11, 45, 2 
(0, 19, 78, 3)
0, 6, 49, 2 
(0, 10, 86, 4)
0, 1, 50, 5 
(0, 2, 89, 9)
.029
ISWT (mo) 157 6 126 156 6 111 171 6 130 146 6 135 .637
Survival (y) 772 6 484 830 6 488 820 6 507 664 6 445 .121
RHC
 mPAP (mmHg) 43 6 12 35 6 8 40 6 9 54 6 8 ,.001
 mRAP (mmHg) 15 6 5 13 6 5 15 6 5 16 6 6 .011
 PAWP (mmHg) 21 6 5 23 6 5 21 6 5 19 6 3 ,.001
 CI (L/m2) 2.6 6 0.7 2.9 6 0.7 2.5 6 0.7 2.5 6 0.8 .008
 PVRI (dyne·sec·m2) 720 6 483 357 6 182 622 6 316 1193 6 455 ,.001
 SvO
2
 (%) 64 6 9 67 6 8 63 6 9 62 6 10 .007
 DPG (mmHg) 4 6 9 24 6 2 3 6 2 14 6 6 ,.001
 TPG (mmHg) 21 6 11 12 6 5 18 6 6 34 6 8 ,.001
 SPG (mmHg) 47 6 21 33 6 13 42 6 16 68 6 15 ,.001
 MAP (mmHg) 151 6 30 113 6 20 144 6 25 142 6 28 .002
 mPAP-to-MAP ratio 0.43 6 0.16 0.32 6 0.08 0.42 6 0.16 0.55 6 0.13 ,.001
Spirometry
 FEV1 (% predicted) 70 6 19 74 6 17 68 6 20 67 6 20 .139
 FVC (% predicted) 72 6 18 73 6 16 73 6 17 69 6 20 .401
 TLCO (% predicted) 47 6 19 55 6 17 51 6 18 36 6 16 ,.001
Cardiac MRI
 RV EDV index (mL·m22) 89 6 31 85 6 31 87 6 31 93 6 30 .383
 RV ESV index (mL·m22) 49 6 23 42 6 22 47 6 19 59 6 24 ,.001
 RV EF (%) 46 6 13 53 6 12 46 6 10 38 6 11 ,.001
 RV mass index (mL·m22) 19 6 10 17 6 10 18 6 8 24 6 11 .001
 LV EDV index (mL·m22) 68 6 21 77 6 21 70 6 19 56 6 20 ,.001
 LV ESV index (mL·m22) 24 6 14 27 6 15 25 6 13 20 6 13 .019
 LV EF (%) 65 6 12 66 6 13 65 6 10 65 6 12 .991
 LV mass index (mL·m22) 56 6 20 59 6 22 58 6 21 51 6 16 .131
 PA RAC (%) 12 6 9 14 6 10 14 6 9 8 6 5 ,.001
 VMI ratio 0.36 6 0.19 0.30 6 0.16 0.32 6 0.11 0.49 6 0.21 ,.001
 IV septal angle (degrees) 154 6 20 141 6 10 157 6 14 174 6 17 ,.001
 Left atrial volume index (mL·m22) 62 6 28 65 6 24 70 6 32 49 6 24 ,.001
 Stroke volume (mL) 82 6 25 93 6 27 83 6 20 68 6 22 ,.001
 Black blood score 3 6 1 2 6 1 3 6 1 3 6 1 ,.001
Note.—Continuous variables are presented as mean 6 standard deviation. Categorical variables are presented as number, with percentage 
in parentheses. Analysis of variance was used to calculate signiicance of diference between groups for continuous variables, and x2 test was 
for categorical variables. CI = cardiac index, DPG = diastolic pulmonary gradient, EDV = end-diastolic volume, EF = ejection fraction, ESV = 
end-systolic volume, FEV1 = forced expiratory volume in one second, FVC = forced vital capacity, ISWT = incremental shuttle walk test, 
IV = interventricular, LV = left ventricle, MAP = mean systemic arterial pressure, mPAP = mean pulmonary artery pressure, mRAP = mean 
right atrial pressure, PA = pulmonary artery, PAWP = pulmonary arterial wedge pressure, PVRI = pulmonary vascular resistance index, 
RAC = relative area change, RV= right ventricle, SPG = systolic pressure gradient (sPAP-PAWP), SvO
2
 = mixed venous oxygen satura-
tions, TLCO = transfer factor for carbon monoxide, TPG = transpulmonary pressure gradient (mPAP-PAWP), VMI = ventricular 
mass index, WHO-FC = World Health Organization-Functional Class.
= 0.190, P = .04 in patients with DPG , 7 mmHg; R = 0.549, 
P , .001 in patients with DPG  7 mmHg). Systolic IVS 
angle correlated with the transpulmonary gradient, PAWP, and 
mPAP (r = 0.77, P , .001; r = 20.20, P = .01; and r = 0.64, P 
, .001, respectively). Other MRI markers had weaker correla-
tions with DPG; the correlations and P values for each metric 
with DPG, transpulmonary gradient, and PVR are provided in 
Johns et al
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systemic pressure. Although IVS 
angle and DPG correlated with all 
three, the strongest correlation was 
for systolic pulmonary arterial pres-
sure–to–systolic systemic pressure 
ratio (R = 0.674 for IVS angle, R = 
0.702 for DPG).
Systolic IVS angle had mod-
est correlations with right ven-
tricular end-diastolic volume (R 
= 0.257, P = .001), right ven-
tricular end-systolic volume (R 
= 0.302, P , .001), left ven-
tricular end-diastolic volume 
(R = 20.231, P = .002), left ven-
tricular end-systolic volume (R = 
20.140, P = .07), and the ratio 
of right-to-left end-diastolic vol-
ume (R = 0.420, P , .001) and 
end-systolic volume (R = 0.462, 
P , .001). At multivariable analysis, IVS angle was inde-
pendently associated with DPG (hazard ratio, 11.807; 95% 
CI: 9.7, 13.9) and right-to-left end-systolic volume ratio 
(hazard ratio, 3.400; 95% CI: 1.3, 5.5).
Prediction of Outcome
Mean follow-up was 2.1 years (standard deviation, 1.3), 
during which there were 48 deaths. Systolic IVS angle en-
abled prediction of all-cause mortality at univariable analy-
sis, with a standardized Cox proportional hazard ratio of 
1.615 (95% CI: 1.253, 2.082; P , .001). Table 4 shows the 
univariate hazard ratios for outcome. Kaplan-Meier analy-
sis, dichotomized by 160°, showed a diference in outcome 
(log-rank test, x2 = 11.02; P , .001) and is available in 
Appendix E1 (online). DPG, PVR, and transpulmonary 
gradient were indicative of death (standardized Cox propor-
tional hazard ratio, 1.708, 1.667, and 1.609 respectively; P 
, .008). IVS angle, DPG, and PVR were all used to predict 
death at 2 years (area under the curve = 0.71 for all three 
factors, P , .001) (Fig 4).
At univariable analysis, PAH vasodilator therapy was associated 
with death (Cox univariable hazard ratio, 1.83; 95% CI: 1.026, 
3.266; P = .04) (log-rank x2 = 4.314, P = .04). However, when 
entered as a dummy variable with septal angle or hemodynamic 
parameters, it did not reach statistical signiicance (P = .26).
Reproducibility of the Interventricular Septal Angle 
Measurement
here was excellent interobserver agreement (intraclass cor-
relation coeicient= 0.902, P , .001). A Bland-Altman plot 
showed a tiny bias of 22% and close 95% limits of agreement 
of 212% to 8%. here was also excellent intraobserver agree-
ment (intraclass correlation coeicient = 0.979, P , .001). 
Bland-Altman analysis showed a tiny bias of 2% and 95% lim-
its of agreement of 24% to 8%. Bland-Altman plots for intra- 
and interobserver reproducibility are provided in Appendix E1 
(online).
Appendix E1 (online). Patients with Cpc-PH had signiicantly 
elevated right ventricular end-systolic volumes and mass (and 
therefore ventricular mass index), reduced stroke volume, and 
right ventricular ejection fraction. In the Cpc-PH cohort, left 
ventricular end-diastolic volume and left atrial volume index 
were reduced, and the pulmonary arterial relative area change 
was signiicantly reduced.
Receiver operating characteristic curve analysis (Appen-
dix E1 [online]) showed that septal angle could be used to 
identify patients with elevated DPG (7 mmHg) with an 
area under the receiver operating characteristic curve of 0.911 
(P , .001). IVS angle also enabled identiication of elevated 
pulmonary vascular resistance (.3 Woods units or .240 
dyne·sec), with an area under the receiver operating charac-
teristic curve of 0.783 (P , .001). In the irst 85 patients (the 
derivation cohort), the Youden index was used to identify a 
septal angle of 160° as a diagnostic threshold for Cpc-PH, 
with 67% sensitivity and 93% speciicity (P , .001). When 
tested in the second 86 patients (the validation cohort), the 
threshold of 160° had 67% sensitivity (95% conidence in-
terval [CI]: 49, 81), 93% speciicity (95% CI: 83, 97), 83% 
positive predictive value (95% CI: 64, 93), and 84% negative 
predictive value (95% CI: 64, 93).
In all patients suspected of having PH, there was a sig-
niicant correlation between the IVS angle and the diastolic 
pulmonary arterial pressure or mPAP (Table 2). here was 
no correlation between the septal angle and either DPG or 
mPAP in patients without PH (P = .15 and P = .53, respec-
tively). All of the groups had an elevated septal angle when 
compared with the groups of patients without PH. Patients 
with PH due to left-sided heart disease had a lower septal 
angle than did the other groups of patients with PH due to 
the combination of Ipc-PH and Cpc-PH.
Hemodynamic Basis of Interventricular Septal Angle
Table 3 shows the correlation between IVS angle and DPG with 
the ratios of mean, diastolic, and systolic pulmonary artery to 
Figure 3: Scatterplots show the correlation of systolic interventricular septal angle with diastolic pul-
monary pressure gradient and pulmonary vascular resistance. Solid line represents the line of best fit, 
and dotted lines represent 95% confidence intervals.
Combined Pre- and Postcapillary Pulmonary Hypertension
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DPG, suggesting the lattening is most associated with the 
pressure gradient between the right and left ventricles.
Patients with Cpc-PH had features of precapillary PH at 
cardiac MRI, such as signiicantly elevated right ventricular 
end-systolic volume and mass (and thus ventricular mass 
index), reduced stroke volume, and right ventricular ejec-
tion fraction. In the Cpc-PH cohort, left ventricular end-
diastolic volume and left atrial volume index were reduced 
(reduced illing). In support of the model that precapillary 
pulmonary vascular remodeling caused reduced precapillary 
Discussion
Our study shows that IVS 
angle can be used to iden-
tify Cpc-PH in patients 
with PAWP greater than 
15 mmHg who are referred 
to a PH center. A systolic 
IVS angle of 160° enabled 
identiication of patients 
with elevated DPG with 
67% sensitivity and 93% 
speciicity and served to 
identify patients with a 
higher risk of death.
We postulate that IVS 
angle represents a good 
estimate for the transpul-
monary gradient, as it is 
a marker of the pressure 
diference between the left 
and right ventricle (23). 
However, it should be 
noted that this is difer-
ent from the DPG, which 
is the pressure diferential 
between the pulmonary 
artery and the mean PAWP 
(a surrogate marker for left 
atrial pressure). We have 
shown that the ratio of pressures between the pulmonary ar-
tery and systemic circulations are accurately relected by the 
IVS angle, particularly at systole. We have also shown a strong 
relationship between the pulmonary arterial–to–systemic pres-
sure ratio and DPG. he association between IVS lattening 
and DPG is independent of other cardiac volumetric and func-
tional measurements. However, the relative volumes of the 
right and left ventricle do contribute to a lesser extent. While 
there is modest correlation between IVS angle and right-to-
left ventricular volume ratio, the strongest correlation is with 
Table 3: Pearson Correlation Coefficients between Hemodynamic Measures in the Whole
Cohort
Characteristic
mPAP:MAP sPAP:SAP dPAP:DAP
Pearson Correlation 
Coeicient P Value
Pearson Correlation 
Coeicient P Value
Pearson Correlation 
Coeicient P Value
IVS angle 0.557 ,.001 0.674 ,.001 0.514 ,.001
DPG 0.637 ,.001 0.702 ,.001 0.662 ,.001
Note.—DAP = diastolic systemic blood pressure, dPAP = diastolic pulmonary arterial pressure, DPG = 
diastolic pulmonary gradient, IVS = interventricular septum, MAP = mean systemic arterial pressure, 
mPAP = mean pulmonary arterial pressure, PAWP = pulmonary arterial wedge pressure, sPAP = systolic 
pulmonary arterial pressure, SAP = systemic systolic blood pressure.
Table 2: Assessment of Systolic Interventricular Septal Angle in Patients with or without Pulmonary Hypertension
Characteristic No PH (n = 114) 1:PAH (n = 230) 2:LHD (n = 171) 3:Resp (n = 52) 4:CTEPH (n = 118) 5:Misc (n = 16)
Mean IVS angle (degrees) 138 (11)*†‡§|| 170 (23)†** 152 (18)*§** 164 (21)†** 166 (22)†** 168 (25)**
Correlation with DPG 0.083 0.618†† 0.637†† 0.728†† 0.662†† 0.719††
Correlation with mPAP 0.112 0.606†† 0.719†† 0.698†† 0.618†† 0.853††
Note.—Signiicant diferences are deined as P , .05 after Bonferroni correction. CTEPH = chronic thromboembolic pulmonary hyper-
tension, DPG = diastolic pulmonary gradient, LHD = left-sided heart disease, Misc = pulmonary hypertension due to miscellaneous causes, 
mPAP = mean pulmonary arterial pressure, PAH = pulmonary arterial hypertension, PH = pulmonary hypertension, Resp = respiratory.
* Diferent to group 1:PAH.
† Diferent to group 2:LHD.
‡ Diferent to group 3:lung disease.
§ Diferent to group 4:CTEPH.
|| Diferent to group 5:misc.
** Diferent to no PH.
†† Correlation is statistically 21signiicant.
Table 4: Univariable Cox Proportional Hazards and 95% CI for Diastolic Pulmonary Gra-
dient, Transpulmonary Gradient, Pulmonary Vascular Resistance, and Systolic Interven-
tricular Septum Angle Standardized by z Score
Characteristic HR 95% CI P Value
DPG 1.708 1.332, 2.189 ,.001
TPG 1.609 1.249, 2.071 ,.001
PVR 1.667 1.332, 2.085 ,.001
mPAP 1.513 1.156, 1.980 .003
Systolic IVS angle 1.615 1.253, 2.082 ,.001
Diastolic IVS angle 1.651 1.236, 2.206 .001
Note.—CI = conidence interval, DPG = diastolic pulmonary gradient, HR = hazard ratio, IVS = inter-
ventricular septum, mPAP = mean pulmonary arterial pressure, PVR = pulmonary vascular resistance, 
TPG = transpulmonary gradient.
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left-sided heart disease. Furthermore, the proposed threshold of 
IVS angle to identify patients with high diastolic pressure gradients 
requires assessment in a separate cohort. Future work is required to 
evaluate this threshold, assess the role of septal measurement in a 
more general cohort of patients with left-sided heart disease, and 
assess similarities with idiopathic pulmonary arterial hypertension.
In conclusion, MRI-derived systolic IVS angle can be used to 
noninvasively identify patients with combined pre- and postcapil-
lary pulmonary hypertension in a cohort of patients suspected of 
having PH, and elevated PAWP. IVS angle can be used to predict 
which patients with left-sided heart disease are at risk for a poor 
outcome and may enable us to identify patients for targeted therapy.
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